Projekt
A 32-week, patient- and rater-blinded, randomized, multicenter, parallel-group study to evaluate disease control and safety in patients with relapsing remitting multiple sclerosis transferred from previous treatment with natalizumab to fingolimod (FTY720)
Abgebrochen · 2012 bis 2012
Müller Stefanie
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Kurzbeschreibung/Zielsetzung
A 32-week, patient- and rater-blinded, randomized, multicenter, parallel-group study to evaluate disease control and safety in patients with relapsing remitting multiple sclerosis transferred from previous treatment with natalizumab to fingolimod (FTY720)
Study: FTY720 - 2324